Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Mol Psychiatry ; 22(7): 936-943, 2017 07.
Article in English | MEDLINE | ID: mdl-28322275

ABSTRACT

Parvalbumin inhibitory interneurons (PVIs) are crucial for maintaining proper excitatory/inhibitory balance and high-frequency neuronal synchronization. Their activity supports critical developmental trajectories, sensory and cognitive processing, and social behavior. Despite heterogeneity in the etiology across schizophrenia and autism spectrum disorder, PVI circuits are altered in these psychiatric disorders. Identifying mechanism(s) underlying PVI deficits is essential to establish treatments targeting in particular cognition. On the basis of published and new data, we propose oxidative stress as a common pathological mechanism leading to PVI impairment in schizophrenia and some forms of autism. A series of animal models carrying genetic and/or environmental risks relevant to diverse etiological aspects of these disorders show PVI deficits to be all accompanied by oxidative stress in the anterior cingulate cortex. Specifically, oxidative stress is negatively correlated with the integrity of PVIs and the extracellular perineuronal net enwrapping these interneurons. Oxidative stress may result from dysregulation of systems typically affected in schizophrenia, including glutamatergic, dopaminergic, immune and antioxidant signaling. As convergent end point, redox dysregulation has successfully been targeted to protect PVIs with antioxidants/redox regulators across several animal models. This opens up new perspectives for the use of antioxidant treatments to be applied to at-risk individuals, in close temporal proximity to environmental impacts known to induce oxidative stress.


Subject(s)
Oxidative Stress/genetics , Parvalbumins/metabolism , Animals , Autism Spectrum Disorder/genetics , Autism Spectrum Disorder/metabolism , Disease Models, Animal , Gyrus Cinguli/metabolism , Humans , Interneurons/metabolism , Interneurons/physiology , Mice , Oxidation-Reduction , Oxidative Stress/physiology , Schizophrenia/genetics , Schizophrenia/metabolism
2.
Cereb Cortex ; 25(5): 1143-51, 2015 May.
Article in English | MEDLINE | ID: mdl-24217989

ABSTRACT

We established a relationship between cognitive deficits and cortical circuits in the LgDel model of 22q11 Deletion Syndrome (22q11DS)-a genetic syndrome with one of the most significant risks for schizophrenia and autism. In the LgDel mouse, optimal acquisition, execution, and reversal of a visually guided discrimination task, comparable to executive function tasks in primates including humans, are compromised; however, there is significant individual variation in degree of impairment. The task relies critically on the integrity of circuits in medial anterior frontal cortical regions. Accordingly, we analyzed neuronal changes that reflect previously defined 22q11DS-related alterations of cortical development in the medial anterior frontal cortex of the behaviorally characterized LgDel mice. Interneuron placement, synapse distribution, and projection neuron frequency are altered in this region. The magnitude of one of these changes, layer 2/3 projection neuron frequency, is a robust predictor of behavioral performance: it is substantially and selectively lower in animals with the most significant behavioral deficits. These results parallel correlations of volume reduction and altered connectivity in comparable cortical regions with diminished executive function in 22q11DS patients. Apparently, 22q11 deletion alters behaviorally relevant circuits in a distinct cortical region that are essential for cognitive function.


Subject(s)
22q11 Deletion Syndrome/pathology , 22q11 Deletion Syndrome/psychology , Behavior, Animal , Cognition , Frontal Lobe/pathology , Nerve Net/pathology , Animals , Discrimination Learning , Disease Models, Animal , Executive Function , Frontal Lobe/cytology , Interneurons/pathology , Male , Mice , Mice, Inbred C57BL , Neurons/pathology , Synapses/pathology
3.
Int J Dev Neurosci ; 29(3): 283-94, 2011 May.
Article in English | MEDLINE | ID: mdl-20833244

ABSTRACT

DiGeorge, or 22q11 deletion syndrome (22q11DS), the most common survivable human genetic deletion disorder, is caused by deletion of a minimum of 32 contiguous genes on human chromosome 22, and presumably results from diminished dosage of one, some, or all of these genes--particularly during development. Nevertheless, the normal functions of 22q11 genes in the embryo or neonate, and their contribution to developmental pathogenesis that must underlie 22q11DS are not well understood. Our data suggests that a substantial number of 22q11 genes act specifically and in concert to mediate early morphogenetic interactions and subsequent cellular differentiation at phenotypically compromised sites--the limbs, heart, face and forebrain. When dosage of a broad set of these genes is diminished, early morphogenesis is altered, and initial 22q11DS phenotypes are established. Thereafter, functionally similar subsets of 22q11 genes--especially those that influence the cell cycle or mitochondrial function--remain expressed, particularly in the developing cerebral cortex, to regulate neurogenesis and synaptic development. When dosage of these genes is diminished, numbers, placement and connectivity of neurons and circuits essential for normal behavior may be disrupted. Such disruptions likely contribute to vulnerability for schizophrenia, autism, or attention deficit/hyperactivity disorder seen in most 22q11DS patients.


Subject(s)
22q11 Deletion Syndrome , Brain/abnormalities , Brain/embryology , Chromosomes, Human, Pair 22/genetics , DiGeorge Syndrome , Mitochondria/metabolism , Neurogenesis , 22q11 Deletion Syndrome/genetics , 22q11 Deletion Syndrome/pathology , 22q11 Deletion Syndrome/physiopathology , Animals , Brain/physiology , Cell Movement , Cell Proliferation , DiGeorge Syndrome/genetics , DiGeorge Syndrome/pathology , DiGeorge Syndrome/physiopathology , Gene Dosage , Humans , Mitochondria/genetics , Morphogenesis , Phenotype
4.
Genes Brain Behav ; 9(8): 933-46, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20659173

ABSTRACT

Catechol-O-methyltransferase (COMT) is a ubiquitously expressed enzyme that maintains basic biologic functions by inactivating catechol substrates. In humans, polymorphic variance at the COMT locus has been associated with modulation of pain sensitivity and risk for developing psychiatric disorders. A functional haplotype associated with increased pain sensitivity was shown to result in decreased COMT activity by altering mRNA secondary structure-dependent protein translation. However, the exact mechanisms whereby COMT modulates pain sensitivity and behavior remain unclear and can be further studied in animal models. We have assessed Comt1 gene expression levels in multiple brain regions in inbred strains of mice and have discovered that Comt1 is differentially expressed among the strains, and this differential expression is cis-regulated. A B2 short interspersed nuclear element (SINE) was inserted in the 3'-untranslated region (3'-UTR) of Comt1 in 14 strains generating a common haplotype that correlates with gene expression. Experiments using mammalian expression vectors of full-length cDNA clones with and without the SINE element show that strains with the SINE haplotype (+SINE) have greater Comt1 enzymatic activity. +SINE mice also exhibit behavioral differences in anxiety assays and decreased pain sensitivity. These results suggest that a haplotype, defined by a 3'-UTR B2 SINE element, regulates Comt1 expression and some mouse behaviors.


Subject(s)
Anxiety/genetics , Catechol O-Methyltransferase/genetics , Hippocampus/enzymology , Pain Threshold/physiology , Pain/genetics , Animals , Anxiety/enzymology , Catechol O-Methyltransferase/metabolism , Exploratory Behavior/physiology , Female , Male , Maze Learning/physiology , Mice , Mice, Inbred Strains , Mutagenesis, Insertional , Pain/enzymology , RNA, Messenger/analysis , Species Specificity
5.
Dev Dyn ; 239(6): 1723-38, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20503368

ABSTRACT

We asked whether specific mesenchymal/epithelial (M/E) induction generates olfactory receptor neurons (ORNs), vomeronasal neurons (VRNs), and gonadotropin-releasing hormone (GnRH) neurons, the major neuron classes associated with the olfactory epithelium (OE). To assess specificity of M/E-mediated neurogenesis, we compared the influence of frontonasal mesenchyme on frontonasal epithelium, which becomes the OE, with that of the forelimb bud. Despite differences in position, morphogenetic and cytogenic capacity, both mesenchymal tissues support neurogenesis, expression of several signaling molecules and neurogenic transcription factors in the frontonasal epithelium. Only frontonasal mesenchyme, however, supports OE-specific patterning and activity of a subset of signals and factors associated with OE differentiation. Moreover, only appropriate pairing of frontonasal epithelial and mesenchymal partners yields ORNs, VRNs, and GnRH neurons. Accordingly, the position and molecular identity of specialized frontonasal epithelia and mesenchyme early in gestation and subsequent inductive interactions specify the genesis and differentiation of peripheral chemosensory and neuroendocrine neurons.


Subject(s)
Cell Differentiation/physiology , Gonadotropin-Releasing Hormone/metabolism , Neurons/cytology , Neurons/metabolism , Olfactory Receptor Neurons/metabolism , Animals , Embryo, Mammalian , Epithelium/metabolism , Mice , Mice, Transgenic , Morphogenesis , Olfactory Mucosa/cytology , Olfactory Mucosa/metabolism , Signal Transduction , Transcription Factors/metabolism
6.
Mol Cell Neurosci ; 39(3): 439-51, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18775783

ABSTRACT

Six genes in the 1.5 Mb region of chromosome 22 deleted in DiGeorge/22q11 deletion syndrome-Mrpl40, Prodh, Slc25a1, Txnrd2, T10, and Zdhhc8-encode mitochondrial proteins. All six genes are expressed in the brain, and maximal expression coincides with peak forebrain synaptogenesis shortly after birth. Furthermore, their protein products are associated with brain mitochondria, including those in synaptic terminals. Among the six, only Zddhc8 influences mitochondria-regulated apoptosis when overexpressed, and appears to interact biochemically with established mitochondrial proteins. Zdhhc8 has an apparent interaction with Uqcrc1, a component of mitochondrial complex III. The two proteins are coincidently expressed in pre-synaptic processes; however, Zdhhc8 is more frequently seen in glutamatergic terminals. 22q11 deletion may alter metabolic properties of cortical mitochondria during early post-natal life, since expression complex III components, including Uqcrc1, is significantly increased at birth in a mouse model of 22q11 deletion, and declines to normal values in adulthood. Our results suggest that altered dosage of one, or several 22q11 mitochondrial genes, particularly during early post-natal cortical development, may disrupt neuronal metabolism or synaptic signaling.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 22/genetics , DiGeorge Syndrome/genetics , Mitochondria/genetics , Mitochondrial Proteins/metabolism , Acyltransferases/genetics , Acyltransferases/metabolism , Animals , Brain/cytology , Brain/metabolism , Cells, Cultured , Computational Biology , Fibroblasts/cytology , Fibroblasts/physiology , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synapses/metabolism , Two-Hybrid System Techniques
7.
Gene Expr ; 13(6): 299-310, 2007.
Article in English | MEDLINE | ID: mdl-17708416

ABSTRACT

The 22q11 Deletion Syndrome (22q11DS, also known as DiGeorge or Velo-Cardio-Facial Syndrome) has a variable constellation of phenotypes including life-threatening cardiac malformations, craniofacial, limb, and digit anomalies, a high incidence of learning, language, and behavioral disorders, and increased vulnerability for psychiatric diseases, including schizophrenia. There is still little clear understanding of how heterozygous microdeletion of approximately 30-50 genes on chromosome 22 leads to this diverse spectrum of phenotypes, especially in the brain. Three possibilities exist: 1) 22q11DS may reflect haploinsufficiency, homozygous loss of function, or heterozygous gain of function of a single gene within the deleted region; 2) 22q11DS may result from haploinsufficiency, homozygous loss of function, or heterozygous gain of function of a few genes in the deleted region acting at distinct phenotypically compromised sites; 3) 22q11DS may reflect combinatorial effects of reduced dosage of multiple genes acting in concert at all phenotypically compromised sites. Here, we consider evidence for each of these possibilities. Our review of the literature, as well as interpretation of work from our laboratory, favors the third possibility: 22q11DS reflects diminished expression of multiple 22q11 genes acting on common cellular processes during brain as well as heart, face, and limb development, and subsequently in the adolescent and adult brain.


Subject(s)
DiGeorge Syndrome/genetics , Gene Dosage/physiology , Gene Expression , Aneuploidy , Animals , Gene Expression Regulation, Developmental , Humans , Mice , Models, Biological , Phenotype
8.
Mol Cell Neurosci ; 33(4): 412-28, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17097888

ABSTRACT

We evaluated the consequences of heterozygous chromosome 22q11 deletion - a significant genetic risk for schizophrenia - for expression levels and patterns of a subset of 22q11 genes implicated in schizophrenia and other phenotypes in mouse models of 22q11 deletion syndrome (22q11DS). In deleted embryos, expression levels of at least nine 22q11 orthologues decline by 40-60% in the frontonasal mass/forebrain and other 22q11DS phenotypic sites (branchial and aortic arches, limb buds); however, coincident expression patterns of 22q11 and Snail genes - diagnostic for neural crest-derived mesenchyme - are unchanged, and Snail1 expression levels do not decline. Subsequently, 22q11 mRNA levels are reduced by 40-60% in the brains of developing, adolescent and adult deleted mice without altered expression patterns, dysmorphology or reduced cell density. Apparently, in deleted individuals, 22q11 gene expression declines across otherwise stable cell populations, perhaps disrupting individual cell function via diminished dosage. Such changes might contribute to schizophrenia vulnerability in 22q11DS.


Subject(s)
Brain , Chromosome Deletion , DiGeorge Syndrome/genetics , Gene Dosage , Gene Expression Regulation, Developmental/genetics , Age Factors , Animals , Animals, Newborn , Brain/embryology , Brain/growth & development , Brain/pathology , Disease Models, Animal , Electrophoretic Mobility Shift Assay/methods , Embryo, Mammalian , Humans , In Situ Hybridization/methods , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction/methods , Snail Family Transcription Factors , Syndrome , Transcription Factors/genetics , Transcription Factors/metabolism
9.
Neuroscience ; 140(1): 111-22, 2006 Jun 19.
Article in English | MEDLINE | ID: mdl-16564641

ABSTRACT

We evaluated the activity of the atypical antipsychotic drug olanzapine on differentiation and gene expression in adult neural precursor cells in vitro. Neural precursors obtained from forebrain subventricular zone (SVZ)-derived neurospheres express a subset (13/24) of receptors known to bind olanzapine at high to intermediate affinities; in contrast, all 24 are expressed in the SVZ. In the presence of 10 nM, 100 nM or 1 microM olanzapine, there is no significant change in the frequency of oligodendrocytes, neurons, GABAergic neurons and astrocytes generated from neurosphere precursors. In parallel, there is no apparent change in cell proliferation in response to olanzapine, based upon bromodeoxyuridine incorporation. There are no major changes in cytological differentiation in response to the drug; however, at one concentration (10 nM) there is a small but statistically significant increase in the size of glial fibrillary acidic protein-labeled astrocytes derived from neurosphere precursors. In addition, olanzapine apparently modulates expression of one serotonin receptor -- 5HT2A -- in differentiating neurosphere cultures; however, it does not modify expression of several other receptors or schizophrenia vulnerability genes. Thus, olanzapine has a limited influence on differentiation and gene expression in adult neural precursor cells in vitro.


Subject(s)
Neurons/drug effects , Prosencephalon/cytology , Selective Serotonin Reuptake Inhibitors/pharmacology , Stem Cells/drug effects , Animals , Benzodiazepines/pharmacology , Bromodeoxyuridine/metabolism , Cerebral Ventricles/cytology , Cerebral Ventricles/drug effects , Dose-Response Relationship, Drug , Gene Expression/drug effects , Immunohistochemistry/methods , In Vitro Techniques , Mice , Nerve Tissue Proteins/metabolism , Neurons/physiology , Olanzapine , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction/methods , Stem Cells/physiology
10.
Proc Natl Acad Sci U S A ; 100(24): 14433-8, 2003 Nov 25.
Article in English | MEDLINE | ID: mdl-14614146

ABSTRACT

Deletions at 22q11.2 are linked to DiGeorge or velocardiofacial syndrome (VCFS), whose hallmarks include heart, limb, and craniofacial anomalies, as well as learning disabilities and increased incidence of schizophrenia. To assess the potential contribution of 22q11 genes to cognitive and psychiatric phenotypes, we determined the CNS expression of 32 mouse orthologs of 22q11 genes, primarily in the 1.5-Mb minimal critical region consistently deleted in VCFS. None are uniquely expressed in the developing or adult mouse brain. Instead, 27 are localized in the embryonic forebrain as well as aortic arches, branchial arches, and limb buds. Each continues to be expressed at apparently constant levels in the fetal, postnatal, and adult brain, except for Tbx1, ProDH2, and T10, which increase in adolescence and decline in maturity. At least six 22q11 proteins are seen primarily in subsets of neurons, including some in forebrain regions thought to be altered in schizophrenia. Thus, 22q11 deletion may disrupt expression of multiple genes during development and maturation of neurons and circuits compromised by cognitive and psychiatric disorders associated with VCFS.


Subject(s)
Brain/growth & development , Brain/metabolism , Chromosomes, Human, Pair 22/genetics , Abnormalities, Multiple/genetics , Adolescent , Adult , Aged , Animals , Brain/embryology , Child , Chromosome Deletion , Cognition Disorders/genetics , Craniofacial Abnormalities/genetics , Gene Expression , Gene Expression Profiling , Heart Defects, Congenital/genetics , Humans , Limb Deformities, Congenital/genetics , Male , Mice , Mice, Inbred ICR , Mice, Knockout , Middle Aged , Oligonucleotide Array Sequence Analysis , Rats , Schizophrenia/genetics , Syndrome
11.
Dev Biol ; 261(1): 82-98, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-12941622

ABSTRACT

We asked whether mesenchymal/epithelial (M/E) interactions regulate retinoic acid (RA) signaling in the olfactory placode and whether this regulation is similar to that at other sites of induction, including the limbs, branchial arches, and heart. RA is produced by the mesenchyme at all sites, and subsets of mesenchymal cells express the RA synthetic enzyme RALDH2, independent of M/E interactions. In the placode, RA-producing mesenchyme is further distinguished by its coincidence with a molecularly distinct population of neural crest-associated cells. At all sites, expression of additional RA signaling molecules (RARalpha, RARbeta, RXR, CRABP1) depends on M/E interactions. Of these molecules, RA regulates only RARbeta, and this regulation depends on M/E interaction. Expression of Fgf8, shh, and Bmp4, all of which are thought to influence RA signaling, is also regulated by M/E interactions independent of RA at all sites. Despite these common features, RALDH3 expression is distinct in the placode, as is regulation of RARbeta and RALDH2 by Fgf8. Thus, M/E interactions regulate expression of RA receptors and cofactors in the olfactory placode and other inductive sites. Some aspects of regulation in the placode are distinct, perhaps reflecting unique roles for additional local signals in neuronal differentiation in the developing olfactory pathway.


Subject(s)
Olfactory Pathways/embryology , Tretinoin/physiology , Aldehyde Oxidoreductases/genetics , Animals , Culture Techniques , Epithelium/embryology , Epithelium/physiology , Fibroblast Growth Factor 8 , Fibroblast Growth Factors/genetics , Gene Expression Regulation, Developmental , In Situ Hybridization , Mesoderm/cytology , Mesoderm/physiology , Mice , Mice, Inbred ICR , Mice, Transgenic , Neural Crest/embryology , Neural Crest/physiology , Olfactory Pathways/physiology , Receptors, Retinoic Acid/genetics , Signal Transduction
12.
Schizophr Bull ; 27(3): 457-76, 2001.
Article in English | MEDLINE | ID: mdl-11596847

ABSTRACT

To account for the complex genetics, the developmental biology, and the late adolescent/early adulthood onset of schizophrenia, the "two-hit" hypothesis has gained increasing attention. In this model, genetic or environmental factors disrupt early central nervous system (CNS) development. These early disruptions produce long-term vulnerability to a "second hit" that then leads to the onset of schizophrenia symptoms. The cell-cell signaling pathways involved in nonaxial induction, morphogenesis, and differentiation in the brain, as well as in the limbs and face, could be targets for a "first hit" during early development. These same pathways, redeployed for neuronal maintenance rather than morphogenesis, may be targets for a "second hit" in the adolescent or adult brain. Furthermore, dysregulation of cell-cell signaling by a "first hit" may prime the CNS for a pathologic response to a "second hit" via the same signaling pathway. Thus, parallel disruption of cell-cell signaling in both the developing and the mature CNS provides a plausible way of integrating genetic, developmental, and environmental factors that contribute to vulnerability and pathogenesis in schizophrenia.


Subject(s)
Brain , Cell Communication/physiology , Psychological Theory , Schizophrenia , Brain/abnormalities , Brain/pathology , Brain/physiopathology , Chromosome Deletion , Chromosomes, Human, Pair 22/genetics , Environment , Humans , Neural Pathways/abnormalities , Neural Pathways/pathology , Neural Pathways/physiopathology , Schizophrenia/etiology , Schizophrenia/pathology , Schizophrenia/physiopathology , Tretinoin/adverse effects
13.
Development ; 127(21): 4561-72, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11023860

ABSTRACT

We have previously shown that cultured trunk neural crest cell populations irreversibly lose neurogenic ability when dispersal is prevented or delayed, while the ability to produce other crest derivatives is retained (Vogel, K. S. and Weston, J. A. (1988) Neuron 1, 569-577). Here, we show that when crest cells are prevented from dispersing, cell death is increased and neurogenesis is decreased in the population, as a result of high cell density. Control experiments to characterize the effects of high cell density on environmental conditions in culture suggest that reduced neurogenesis is the result of cell-cell interactions and not changes (conditioning or depletion) of the culture medium. Additionally, we show that the caspase inhibitor zVAD-fmk, which blocks developmentally regulated cell death, rescues the neurogenic ability of high density cultures, without any apparent effect on normal, low-density cultures. We conclude, therefore, that increased cell interaction at high cell densities results in the selective death of neurogenic precursors in the nascent crest population. Furthermore, we show that neurogenic cells in cultured crest cell populations that have dispersed immediately are not susceptible to contact-mediated death, even if they are subsequently cultured at high cell density. Since most early migrating avian crest cells express Notch1, and a subset expresses Delta1 (Wakamatsu, Y., Maynard, T. M. and Weston, J. A. (2000) Development 127, 2811-2821), we tested the possibility that the effects of cell contact were mediated by components of a Notch signaling pathway. We found that neurogenic precursors are eliminated when crest cells are co-cultured with exogenous Delta1-expressing cells immediately after they segregate from the neural tube, although not after they have previously dispersed. We conclude that early and prolonged cell interactions, mediated at least in part by Notch signaling, can regulate the survival of neurogenic cells within the nascent crest population. We suggest that a transient episode of cell contact-mediated death of neurogenic cells may serve to eliminate fate-restricted neurogenic cells that fail to disperse promptly in vivo.


Subject(s)
Apoptosis/physiology , Neural Crest/physiology , Neurons/cytology , Neurons/physiology , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Apoptosis/drug effects , Cell Communication , Cell Death , Cell Differentiation , Cells, Cultured , Cellular Senescence , Cysteine Proteinase Inhibitors/pharmacology , Embryo, Nonmammalian , Homeodomain Proteins/physiology , Intracellular Signaling Peptides and Proteins , Kinetics , Membrane Proteins/genetics , Membrane Proteins/physiology , Neural Crest/cytology , Neurons/drug effects , Quail , Tretinoin/pharmacology
14.
Development ; 127(13): 2811-21, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10851127

ABSTRACT

Avian trunk neural crest cells give rise to a variety of cell types including neurons and satellite glial cells in peripheral ganglia. It is widely assumed that crest cell fate is regulated by environmental cues from surrounding embryonic tissues. However, it is not clear how such environmental cues could cause both neurons and glial cells to differentiate from crest-derived precursors in the same ganglionic locations. To elucidate this issue, we have examined expression and function of components of the NOTCH signaling pathway in early crest cells and in avian dorsal root ganglia. We have found that Delta1, which encodes a NOTCH ligand, is expressed in early crest-derived neuronal cells, and that NOTCH1 activation in crest cells prevents neuronal differentiation and permits glial differentiation in vitro. We also found that NUMB, a NOTCH antagonist, is asymmetrically segregated when some undifferentiated crest-derived cells in nascent dorsal root ganglia undergo mitosis. We conclude that neuron-glia fate determination of crest cells is regulated, at least in part, by NOTCH-mediated lateral inhibition among crest-derived cells, and by asymmetric cell division.


Subject(s)
Ganglia/embryology , Membrane Proteins/metabolism , Neural Crest/embryology , Animals , Bromodeoxyuridine/metabolism , Cell Differentiation , Cell Division , Cell Lineage , Cell Movement , Cells, Cultured , Chick Embryo , Cloning, Molecular , Coturnix/embryology , Drosophila Proteins , Ganglia/cytology , Ganglia, Spinal/embryology , Ganglia, Spinal/metabolism , In Situ Hybridization , Intracellular Signaling Peptides and Proteins , Juvenile Hormones/biosynthesis , Membrane Proteins/biosynthesis , Mitosis , Neuroglia/cytology , Neurons/physiology , Receptors, Notch , Signal Transduction , Time Factors , Transfection
15.
Dev Dyn ; 218(1): 150-9, 2000 May.
Article in English | MEDLINE | ID: mdl-10822267

ABSTRACT

During development, trunk neural crest cells give rise to three primary classes of derivatives: glial cells, melanocytes, and neurons. As part of an effort to learn how neural crest diversification is regulated, we have produced monoclonal antibodies (MAbs) that recognize antigens expressed by neural crest cells early in development. One of these, MAb 7B3 (7B3), was found to recognize an avian transitin-like protein by co-immunostaining with a series of transitin-specific monoclonal antibodies and by Western blot analysis. In neural crest cell cultures, we found that 7B3 initially recognizes the majority of neural crest cells as they emerge from the neural tube. Subsequently, 7B3-immunoreactivity (IR) is progressively restricted to a smaller subpopulation of cells. In fully differentiated trunk neural crest cell cultures, 7B3-IR is expressed only by cells that do not express neuronal markers and lack melanin granules. During development in vivo, 7B3-IR is evident in neural crest cells on the medial, but not the lateral migration pathway, suggesting that it is not expressed by melanocyte precursors. Later, the antigen is detected in non-neuronal, presumptive glial cells in dorsal root ganglia (DRG) and sympathetic ganglia, as well as along ventral roots. Cultures of E5 DRG confirm that 7B3-IR is restricted to non-neuronal cells of ganglia, many of which closely associate with neuronal processes. Therefore, of the three major classes of differentiated trunk neural crest derivatives, 7B3 exclusively recognizes glial cells, including both satellite glia and Schwann cells. Since the pattern of 7B3 expression in vitro mirrors the pattern of glial cell fate-restrictions in the trunk neural crest lineage, and is expressed by neural crest-derived glia in vivo, we conclude that 7B3 is an early pan-glial marker for neural crest-derived glial cells and their precursors.


Subject(s)
Glial Fibrillary Acidic Protein/genetics , Nerve Tissue Proteins/genetics , Neural Crest/cytology , Neural Crest/embryology , Neuroglia/cytology , Neuroglia/physiology , Animals , Antibodies, Monoclonal , Cell Differentiation/physiology , Cell Movement/physiology , Cells, Cultured , Chick Embryo , Ganglia, Spinal/cytology , Gene Expression Regulation, Developmental/physiology , Glial Fibrillary Acidic Protein/analysis , Glial Fibrillary Acidic Protein/immunology , Hybridomas , Intermediate Filament Proteins , Melanocytes/cytology , Mice , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/immunology , Nestin , Neuroglia/chemistry , Neurons/chemistry , Neurons/cytology , Neurons/physiology , Quail , Stem Cells/chemistry , Stem Cells/cytology , Stem Cells/physiology
16.
Neuron ; 23(1): 71-81, 1999 May.
Article in English | MEDLINE | ID: mdl-10402194

ABSTRACT

The importance of lateral inhibition mediated by NOTCH signaling is well demonstrated to control neurogenesis both in invertebrates and vertebrates. We have identified the chicken homolog of Drosophila numb, which suppresses NOTCH signaling. We show that chicken NUMB (c-NUMB) protein is localized to the basal cortex of mitotic neuroepithelial cells, suggesting that c-NUMB regulates neurogenesis by the modification of NOTCH signaling through asymmetrical cell division. Consistent with this suggestion, we show (1) that c-NUMB interferes with the nuclear translocation of activated c-NOTCH-1 through direct binding to the PEST sequence in the cytoplasmic domain of c-NOTCH-1 and (2) that c-NUMB interferes with c-NOTCH-1-mediated inhibition of neuronal differentiation.


Subject(s)
Cerebral Cortex/embryology , Chick Embryo/metabolism , Coturnix/embryology , Juvenile Hormones/metabolism , Membrane Proteins/metabolism , Neurons/cytology , Receptors, Cell Surface , Transcription Factors , Amino Acid Sequence/genetics , Animals , Cell Differentiation/physiology , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Chick Embryo/cytology , Chick Embryo/physiology , Chickens/genetics , Cloning, Molecular , Coturnix/metabolism , Drosophila Proteins , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/metabolism , Embryo, Nonmammalian/physiology , Epithelial Cells/metabolism , Juvenile Hormones/genetics , Membrane Proteins/physiology , Mice , Molecular Sequence Data , Receptor, Notch1 , Sequence Homology, Amino Acid , Signal Transduction/physiology , Tissue Distribution/physiology
17.
J Comp Neurol ; 349(2): 303-24, 1994 Nov 08.
Article in English | MEDLINE | ID: mdl-7860785

ABSTRACT

This study has examined the developing glial architecture of the optic pathway and has related this to the changing organization of the constituent axons. Immunocytochemistry was used to reveal the distribution of glial profiles, and DiI was used to label either radial glial profiles or optic axons. Electron microscopy was used to determine the distribution of glial profiles, axons, growth cones, and wrists at different locations along the pathway. Three different glial boundaries were defined: Two of these are revealed as changes in the distribution of vimentin-immunoreactive profiles occurring in the prechiasmatic optic nerve and at the threshold of the optic tract, respectively, and one by the presence of glial fibrillary acidic protein (GFAP)-immunoreactive profiles at the chiasmatic midline. The latter, midline boundary may be related to the segregation of nasal from temporal optic axons. The boundary at the threshold of the optic tract coincides with the segregation of dorsal from ventral optic axons that emerges at this location in the pathway. The segregation of old from young optic axons is shown to occur only gradually along the pathway. Glial profiles are most frequent in the deeper parts of the tract, coursing parallel to the optic axons and orthogonal to their usual radial axis. These are suggested to arise from later-growing radial glial fibers that are diverted to grow amongst the older optic axons. Those glial profiles may subsequently impede axonal invasion, thus creating the chronotopic reordering by forcing the later-arriving axons to accumulate superficially.


Subject(s)
Axons/ultrastructure , Ferrets/anatomy & histology , Neuroglia/ultrastructure , Optic Chiasm/ultrastructure , Animals , Axons/chemistry , Embryonic and Fetal Development/physiology , Ferrets/embryology , Ferrets/metabolism , Glial Fibrillary Acidic Protein/analysis , Immunohistochemistry , Neuroglia/chemistry , Optic Chiasm/chemistry , Vimentin/analysis
18.
Plant Physiol ; 69(2): 465-8, 1982 Feb.
Article in English | MEDLINE | ID: mdl-16662230

ABSTRACT

Ochromonas danica Pringsheim, a freshwater chrysomonad, converts d-glucose into l-ascorbic acid over a metabolic pathway that ;inverts' the carbon chain of the sugar. In this respect, l-ascorbic acid formation resembles that found in ascorbic acid-synthesizing animals. It differs from this process in that d-galacturonate and l-galactono-1,4-lactone, rather than d-glucuronate and l-gulono-1,4-lactone, enhance production of ascorbic acid and repress the incorporation of (14)C from d-[1-(14)C]glucose into ascorbic acid.

SELECTION OF CITATIONS
SEARCH DETAIL